A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease (DED)
Interventions
DRUG:
0.25% RCI001 Ophthalmic Solution
DRUG:
Placebo Ophthalmic Solution (vehicle)
Sponsor
ORA, Inc.